- 
                        Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?
                        30 Sep 2025 13:11 GMT
                         … inhibitor from Vertex Pharmaceuticals, has spurred further … drugs fail, doctors often move to off-label options including antidepressants … biotech’s trials. Axsome is now planning a replacement trial … pivot toward new treatment strategies, including psychedelics … 
- 
                        Dededo meth raid trial still on despite attorney’s status issues
                        03 Sep 2025 22:57 GMT
                        
                           …  the speedy trial clock are still unresolved.
                          Darwin Papa Savella, Danny Sangil …  nearly 10 grams of methamphetamine, drug paraphernalia, cash, and stolen property …  drug paraphernalia with residue and multiple stolen items, court documents stated.
                          Savella …
                         
- 
                        Fibromyalgia Treatment Landscape: FDA Approves TONMYA, First New Therapy In 15 Years  Delveinsight's Perspective On Market Impact, Competitive Landscape And Other Pipeline Therapies
                        22 Aug 2025 03:03 GMT
                        
                           … fibromyalgia treatment approved by the FDA  …  Phase 3 trials (RELIEF and … antidepressant medications.
                          Explore the Fibromyalgia Drug Battle: TONMYA vs. LYRICA vs. CYMBALTA vs. SAVELLA … consulting services to pharmaceutical companies, biotechnology firms, and …
                         
- 
                        Tonix ends 16-year hiatus in fibromyalgia treatment
                        18 Aug 2025 12:15 GMT
                         … after claiming FDA approval for Tonmya, an oral drug used to …  and AbbVie's Savella (milnacipran), which dominate the  … of Washington School of Medicine said that fibromyalgia currently … quot;Tonmya is a novel treatment approach that targets nonrestorative  … 
- 
                        TNX-102 SL Now Fourth FDA-Approved Treatment for Fibromyalgia
                        19 Aug 2025 04:50 GMT
                         … trials also demonstrated good tolerance of the treatment, as did a third trial … Pharmaceuticals announces FDA approval of Tonmya (cyclobenzaprine HCl sublingual tablets) for the treatment … #47;biotech/;forest-and-cypress-announce-fda-approval-of-savella-tm- … 
- 
                        FDA approves landmark fibromyalgia drug that works like no other
                        18 Aug 2025 22:35 GMT
                         …  action. In clinical trials, this quick delivery  …  Executive Officer of Tonix Pharmaceuticals. “At Tonix, we …  FDA-approved medications like Lyrica (pregabalin), Cymbalta (duloxetine) and Savella  …  drug is also currently in the trial stage for the treatment  … 
- 
                        Tonix Pharma Gears Up For Key FDA Decision Today, Stock  Up Over 500% In 5 Months
                        15 Aug 2025 10:32 GMT
                         …  Pharmaceuticals Holding Corp. (TNXP) is expected to hear from the FDA  … its decision on the investigational drug TNX-102 … 's Savella are some of the FDA-approved drugs for fibromyalgia. …  and the first new drug for treating fibromyalgia in  … 
- 
                        With FDA nod, Tonix's Tonmya becomes first new fibromyalgia treatment in more than 16 years
                        16 Aug 2025 04:43 GMT
                        
                           … Cymbalta and AbbVie’s Savella—were approved in a …  a tertiary amine tricyclic antidepressant, Tonmya offers a new … 000 patients. Across both trials, Tonmya significantly reduced  … treatment from a pill to a sublingual formulation.
                          In 2010, Jazz Pharmaceuticals …
                         
- 
                        US FDA approves Tonix Pharma’s drug to manage pain related to chronic condition
                        15 Aug 2025 20:48 GMT
                         … Food and Drug Administration has approved Tonix Pharmaceuticals’ drug to manage …  is a pill designed for bedtime treatment to improve  … misunderstood and dismissed by doctors but is now  … that the currently available medication options have limited effectiveness … 
- 
                        Biotech Stocks Facing FDA Decision In August 2025
                        30 Jul 2025 15:53 GMT
                        
                           …  biotech companies whose drug candidates are at the FDA  … Pharmaceuticals Inc. (IONS)
                          Ionis Pharma's Donidalorsen, an investigational RNA-targeted medicine … drug, Rilzabrutinib, being developed for the treatment of immune thrombocytopenia, awaits the FDA …